FDA Investigator Jennifer L Huntington

Jennifer L Huntington has inspections in 9 countries as of 23 Oct 2023. Jennifer L Huntington has collaborated with a combinined 4663 experts on various inspections, contributing to compliance and improvement across diverse sectors.

Investigator Details

Number of Inspected Sites:
86
Last Inspection Date:
23 Oct 2023
Investigator Role:
FDA Investigator
Redica ID:
Country:
United States of America, India, Germany, Korea (Republic of), France, Singapore, United Kingdom of Great Britain and Northern Ireland, Indonesia
Co-Investigator(s):
Aaron F Coleman, Adalberto Cajigas, Adam J Taylor, Adam M Derr, Ademola O Daramola, Alan A Rivera, Alan P Kurtzberg, Almaris N Alonso, Ana Delp Cintron, Ana P Barido, Anastasia M Shields, Andrea Dcharles Julien, Angela E Glenn, Angela F Orozco, Ariel Cruz Figueroa, Arsen Karapetyan, Barbara D Wright, Barbara J Rincon, Barbara T Carmichael, Benita C Okeke, Bill Tacket, Jr, Bonita S Chester, Brandon C Heitmeier, Brandy N Lepage, Brittny C Cargo, Byungja E Marciante, CDR Ileana Barreto Pettit, CDR Rochelle B Young, RPh, MSA, CDR Sean T Creighton, Charanjeet Jassal, Charles R Cote, RIC, Cherie T Parker, Cheryl A Clausen, Chiaochun J Wang, Christie A Soto, Christopher T Middendorf, Clifton C Francis, Clinton J Lott, Conner N Mann, Courtney A Gilbert, Courtney A Hunt, Courtney Hunt, Craig A Garmendia, Cynthia Bolte, Cynthia L Bolte, Cynthia L Medlin, Damaris Y Hernandez, Dandan Wang, PhD, Darren S Brown, Daryl A Dewoskin, David M Wilkinson, Dawn C Olenjack, Dawn M Mccabe, Dell S Moller, Demario L Walls, Denise M Digiulio, Douglas Florentino, Dr. Barbara D Paul, PhD, Dyvette Arline, Eduardo Carbonell, Edwards, Edwin J Gorney, Eileen A Liu, Eric M Mueller, PharmD, Ethan P Stegman, Fabian Nchaparro Rodriguez, Farhana Khan, Felix Maldonado, Frances M Rivera, Frances M Rivera Rosario, Francis A Guidry, Gabriel E Muniz, George J Flynn, Gerardo Z Vazquez, German Rivera, Gina C Chen, Gina Eng, Goran Periz, PhD, Gretchen M Laws, H Ljamilla Selby, Hala L Selby, Harshal J Desai, Hecter Jcolon Torres, Hector J Colon Torres, Hugh M Mcclure, II, Hunt, Ivis Lnegron Torres, Ivy E Sweeney, James R Birkenstamm, Jason D Abel, Jason P Aun, Javier O Vega, Jean A Peeples, Jennifer D Hollstrom, Jennifer Lalama, Jennifer M Gogley, Jennifer M Menendez, Jessica L Pressley, Jessica P Mcalister, Jingbo Xiao, Joann Walters Salvatierra, Joanne E King, Jogy George, John D White, John E Russell, Jorge L Guadalupe, Jose Alopez Rubet, Jose E Melendez, DDC, Jose Perez Soto, Jose R Hernandez, Jose Velez, Joshua J Silvestri, Juna P Page, June P Page, Junho Pak, Justin A Boyd, Karen G Hirshfield, Karen M Rodriguez, Katherine M Taylor, Katherine Szestypalow, Kejun Cheng, Kerry Ann Latham, Kim Lthomas Cruse, Kip J Hanks, Krista W Whitten, Kristy E Zuroski, Lakisha N Morton, Latorie S Jones, Laura L Staples, LCDR Michael H Tollon, Lesley K Satterwhite, Leslie A Cartmill, Libia M Lugo, Linda F Murphy, Linda K Matheny, Lisa Sg Shelton, Lissette Paiz, Lorie S Hannappel, LT Kimberly M Hull, LT Richard A Lyght, LT Tamara J Henderson, Luis A Dasta, Mabany Lizardi, Marc Balzarini, Marcellinus D Dordunoo, Maria Estrella, Maria V Price, Marie F Morin, Mark Sassaman, Mark W Rivero, Markeesa M Scales, Martrice A Packer, Marvin D Jones, Mary F Bodick, Matthew F Duff, Meghan Murphy, Melinda B Lewis, Melissa J Garcia, Michael A Charles, Michael C Lombardi, Michael E Maselli, Michael R Goga, Michele L Obert, Michele Perry Williams, Miguel A Martinez, Mihaly S Ligmond, Mizanne E Lewis, Mra Mcculloughj, Muralidhara B Gavini, PhD, Nancy G Schmidt, Nancy L Neiger, Nancy M Espinal, Neda Hamandi, Neil J Bonzagni, PhD MPH, Nicole E Knowlton, Nicole M Bell, Nije A Thomas, Noreen Muniz, Ormond, Pal S Mayasandra, Parul M Patel, Patrick C Klotzbuecher, Paul A Bonneau, Paul A Licata, Paul H Dakin, Paul L Bellamy, Paul L Figarole, Jr, Peter E Baker, Pratik S Upadhyay, DDC, Qin Xu, Rachel A Gomez, Rachel A Peters, Raihan A Chowdhury, Ramesh Sood, Ramon H Pabon Aponte, Ravindra K Kaallwal, Rebecca Rodriguez, Regan T Harp, Renee S Blosser, Richard K Vogel, Rina Bhikha, Robert C Coleman, Robert C Steyert, Robert D Tollefsen, Robert M Barbosa, Robert W Calais, Roger F Zabinski, Ronald T Weber, Rose Xu, Roy R Rinc, Rozelle G Smith, Rumany C Penn, PharmD, Ruth A Williams, Samantha J Bradley, Sangeeta M Khurana, PhD, Sarah E Mcmullen, Satheesh Thomas, Saundrea A Munroe, Scott T Ballard, Sharon Giamberini, Shelby N Marler, Shelby N Turner, Shelton L Stribling, Sherbert Samuels, Sherbet L Samuels, Sheri L Stephenson, Shirley J Berryman, Shondra N Gipson, Simone E Pitts, Sina Shojaee, Sixto M Mercado Rios, Stacey L Witherwax, State Agency, Stephanie D Crockett, Stephen D Brown, Stephen J Koniers, Steven A Brettler, Steven D Dittert, Steven J Rush, Steven P Donald, Susan M Corrales, Susan M Turcovski, Susan P Bruederle, Suzanne N Vallez, Tamil Arasu, PhD, Teresa I Navas, Terri L Dodds, Thomas J Arista, Torrance J Slayton, Tracey L Harris, Travis E Chapman, Truong Xuan Nguyen (Andy), Victor Spanioli, Virginia L Meeks, Vivin George, Vlada Matusovsky, Wendy G Tan, PhD, William J Leonard, Xiujing L Baggett, Yasamin Ameri, Yumi J Hiramine, Zada L Giles, Zakaria Wahba

Jennifer L Huntington's Documents

Publish Date Document Type Title
March, 2019 FDA 483 Option Care Enterprises, Inc. dba Option Care - Form 483, 2019-03-12
December, 2019 FDA 483 Infusion Systems of SW Florida Inc. dba Myerlee Pharmacy - Form 483, 2019-12-17
April, 2017 FDA 483 Response Cosmetic Solutions, LLC - Form 483R, 2017-04-14
January, 2018 EIR OXYGEN DEVELOPMENT, L.L.C. - EIR, 2018-01-19
April, 2017 EIR Cosmetic Solutions, LLC - EIR, 2017-04-14
June, 2021 FDA 483 PETNET SOLUTIONS, INC. - Form 483, 2021-06-24
August, 2019 EIR KRS Global Biotechnology, Inc - EIR, 2019-08-14
May, 2021 FDA 483 Actavis Laboratories FL, Inc. - Form 483, 2021-05-25
November, 2015 FDA 483 A.I.G. TECHNOLOGIES, INC. - Form 483, 2015-11-17
August, 2018 FDA 483 Capzer Pharmaceuticals - Form 483, 2018-08-29
March, 2018 FDA 483 Exxonmobil Product Solutions Company - Form 483, 2018-03-09
January, 2018 FDA 483 Response OXYGEN DEVELOPMENT, L.L.C. - Form 483R, 2018-02-01
February, 2018 FDA 483 Lex Inc - Form 483, 2018-02-14
February, 2020 FDA 483 Alkem Laboratories Limited - Form 483, 2020-02-21
April, 2017 FDA 483 Cosmetic Solutions, LLC - Form 483, 2017-04-14
December, 2018 FDA 483 Tropichem Research Labs, LLC dba Vetio - Form 483, 2018-12-14
December, 2017 FDA 483 PharMEDium Services, LLC. - Form 483, 2017-12-15
July, 2018 FDA 483 Actavis Laboratories FL, Inc. - Form 483, 2018-07-19
October, 2018 FDA 483 Promise Pharmacy, LLC - Form 483, 2018-11-12
August, 2017 FDA 483 Vi-Jon, LLC - Form 483, 2017-08-18
February, 2020 FDA 483 Intas Pharmaceuticals Limited - Form 483, 2020-02-28
May, 2019 FDA 483 Coast Quality Pharmacy, LLC dba Anazao Health - Form 483, 2019-05-09
August, 2019 FDA 483 KRS Global Biotechnology, Inc - Form 483, 2019-08-20
October, 2016 FDA 483 Tri-Coast Pharmacy - Form 483, 2016-10-21
May, 2017 EIR Bausch & Lomb Incorporated - EIR, 2017-05-26
April, 2018 FDA 483 Home Care Pharmacy of Palm Coast, Inc. - Form 483, 2018-04-25
August, 2019 FDA 483 Trilogy Laboratories, LLC - Form 483, 2019-08-27
June, 2019 FDA 483 NEULAND LABORATORIES LIMITED - Form 483, 2019-06-21
September, 2018 FDA 483 Sincerus Florida, LLC - Form 483, 2018-09-17
August, 2016 FDA 483 Pharmatech LLC - Form 483, 2016-08-09
October, 2017 FDA 483 SOFGEN PHARMACEUTICALS LLC - Form 483, 2017-10-18
January, 2017 FDA 483 SOFGEN PHARMACEUTICALS LLC - Form 483, 2017-01-20
September, 2022 FDA 483 Opto-Pharm Pte Ltd - Form 483, 2022-09-01
May, 2017 FDA 483 Bausch & Lomb Incorporated - Form 483, 2017-05-26
July, 2019 FDA 483 SHL Pharma LLC - Form 483, 2019-07-11
January, 2019 FDA 483 Complete Pharmacy and Medical Solutions, LLC dba Complete Pharmaceutics - Form 483, 2019-01-23
September, 2019 FDA 483 Tarmac Products, Inc. - Form 483, 2019-09-27
November, 2018 FDA 483 Ceva Animal Health - Form 483, 2018-11-09
August, 2016 FDA 483 Response Pharmatech LLC - Form 483R, 2016-08-25
November, 2015 FDA 483 Response A.I.G. TECHNOLOGIES, INC. - Form 483R, 2015-12-02
October, 2018 FDA 483 Red Mountain Inc - Form 483, 2018-10-11
November, 2015 EIR A.I.G. TECHNOLOGIES, INC. - EIR, 2015-11-17
August, 2018 FDA 483 Westlab Pharmacy, Inc. dba Westlab Pharmacy - Form 483, 2018-08-15
May, 2021 EIR Actavis Laboratories FL, Inc. - EIR, 2021-05-25
January, 2018 FDA 483 OXYGEN DEVELOPMENT, L.L.C. - Form 483, 2018-01-17
May, 2018 FDA 483 Coast Quality Pharmacy, LLC dba Anazao Health - Form 483, 2018-05-07
January, 2018 EIR OXYGEN DEVELOPMENT, L.L.C. - EIR, 2018-01-17
February, 2019 FDA 483 Pavilion Compounding Pharmacy - Form 483, 2019-02-08
December, 2019 FDA 483 Transdermal Delivery Solutions Corp. dba Hypospray Pharma - Form 483, 2019-12-03
September, 2019 FDA 483 Elevate Oral Care - Form 483, 2019-09-06
October, 2021 FDA 483 Norbrook Laboratories Limited - Form 483, 2021-10-15

Experience Redica System's NEW investigator profiles and dashboards

Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:

  • Total inspections conducted
  • 483 rate
  • OAI rate
  • Warning Letter rate
  • Inspections by Industry, Scope, and Inspection Reason
  • And much more

Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.


Talk to sales to access our investigator profiles

Loading...

Investigator Profiles Are Just the Tip of the Iceberg

Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:

Inspection Intelligence

  • Pre-Approval Inspection (PAI) trends
  • The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
  • Latest 483s: see what the trends are across all FDA Investigators
  • CFR Heatmap: Citations aggregated by Subpart by Year

Vendor Intelligence

  • Full inspection histories for your vendors down to the specific site level
  • All of the functionality mentioned above but isolated to just your vendors

Regulatory Intelligence

  • Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
  • All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more